Siolta Therapeutics

Siolta Therapeutics is a clinical-stage biotechnology company with the mission of alleviating the suffering of millions of patients affected by chronic inflammatory diseases through novel microbiome-based therapeutics. Siolta Therapeutics leverages human infant gut microbiome and clinical data to understand the early microbial networks that promote the development of a healthy gut microbiome. Our science focuses on decoding these interactions and identifying specific microbes that promote proper gut microbiome development early in life to prevent immune dysfunction and support healthy childhood development. This unique platform enables us to develop and test novel microbiome-based therapies for the treatment and prevention of diseases.